financetom
Business
financetom
/
Business
/
FBI looking into Tesla Supercharger damage incident, latest in series of vandalism acts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FBI looking into Tesla Supercharger damage incident, latest in series of vandalism acts
Apr 8, 2025 3:56 PM

April 8 (Reuters) - The Federal Bureau of Investigation said it was looking into an

incident that left a Tesla Supercharger station damaged in a city in Washington in the

wee hours of Tuesday.

Electrek first reported the incident, saying an "explosion" led to a temporary shutdown of

the charging station. Reuters could not independently verify if there was an explosion.

"We are aware of the incident and are working with our partners to determine exactly what

happened," the FBI told Reuters in an email. It did not provide details.

The police department in Lacey, where the incident occurred, said in a Facebook post: "This

morning at 1:34, officers were dispatched to a malicious mischief after receiving multiple calls

reporting a loud noise in the Sleater Kinney area."

Tesla's electric vehicles, showrooms and chargers have become targets of vandalism in

several countries amid growing "Tesla Takedown" protests against CEO Elon Musk's politics. Musk,

a close ally of U.S. President Donald Trump, has been instrumental in cutting thousands of

federal jobs. In Europe, he has stirred controversy by supporting far-right parties.

Tesla investors and analysts have voiced concern that Musk's actions have damaged the

company's brand, leading to a sharp decline in sales.

Trump has called the violence against Tesla showrooms "domestic terrorism," promising to

punish perpetrators. FBI Director Kash Patel said last month the bureau was probing what he

called "the increase in violent activity toward Tesla," and that it had taken steps to crack

down on such incidents.

The vandalized Tesla Supercharger station, located at 665 Sleater Kinney Road SE in Lacey,

comprises 12 Superchargers, each capable of delivering up to 250 kW of power, according to the

company's website.

Tesla said on its Charging X page that it was coordinating with Washington's energy utility

company Puget Sound Energy to bring back the Superchargers online. The company did not respond

to a Reuters request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
E3 Lithium Narrows Q1 Loss; Company Hasn't Started Commercial Production or Generated Cash Flow
E3 Lithium Narrows Q1 Loss; Company Hasn't Started Commercial Production or Generated Cash Flow
May 24, 2024
08:25 AM EDT, 05/24/2024 (MT Newswires) -- E3 Lithium ( EEMMF ) on Friday reported a narrower loss for the first quarter even though the company has not generated revenues from operations and had an accumulated deficit of $45.2 million at the end of March. The company reported a first-quarter net loss of $2.4 million, or $0.03 per share, compared...
--Cato Keeps Quarterly Dividend at $0.17 per share, Payable June 24 to Shareholders of Record June 10
--Cato Keeps Quarterly Dividend at $0.17 per share, Payable June 24 to Shareholders of Record June 10
May 24, 2024
08:17 AM EDT, 05/24/2024 (MT Newswires) -- Price: 5.73, Change: -0.05, Percent Change: -0.87 ...
Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer
Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer
May 24, 2024
08:25 AM EDT, 05/24/2024 (MT Newswires) -- Verastem Oncology (VSTM) late Thursday reported that an ongoing phase 1/2 clinical trial evaluating avutometinib and defactinib in combination with gemcitabine and nab-paclitaxel in 41 patients with metastatic pancreatic cancer reached an interim partial response rate of 83%. Of 26 patients in all the trial cohorts who have had their first scan while...
Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation
Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation
May 24, 2024
08:17 AM EDT, 05/24/2024 (MT Newswires) -- Organon (OGN) and Shanghai Henlius Biotech said Friday their marketing authorization applications for HLX14, a denosumab biosimilar, have been validated by the European Medicines Agency. The submissions were based on a phase 3 study comparing HLX14 with denosumab in postmenopausal women with osteoporosis, the companies said. Henlius licensed HLX14 to Organon in 2022...
Copyright 2023-2025 - www.financetom.com All Rights Reserved